Human Genome Project
An international research program with the goal of gathering a resource of genomic maps and DNA sequence information that will provide detailed information about the structure, organization, and characteristics of the DNA of humans and other animals. The project began in the mid-1980s and the first phase (sequencing) has been completed in 2000.
Articles on KurzweilAI.net that refer to Human Genome ProjectPredictive Human Genomics Is Here By Terry Grossman
Why Cryosuspension Makes Sense By Terry Grossman
The Last Human By Gregory Stock
Testimony of Ray Kurzweil on the Societal Implications of Nanotechnology By Ray Kurzweil
Singularities and Nightmares By David Brin
Finishing the Unfinished Revolution By Michael L. Dertouzos
When Machines Outsmart Humans By Nick Bostrom
Tearing Toward the Spike By Damien Broderick
The Human Machine Merger: Why We Will Spend Most of Our Time in Virtual Reality in the Twenty-first Century By Ray Kurzweil
The Paradigms and Paradoxes of Intelligence: Building a Brain By Ray Kurzweil
News Articles that refer to Human Genome ProjectVirtually human
The Road to a 1,000-Year Life Span
NSF proposes major program to enhance human performance
Final human genome sequence released
Genetic Predictions: Just a Swab Away
Computer scientists identify future IT challenges
Gene project would seek keys to cancer
New Effort Aims to Unlock Secrets of Cancer Genes
Biology Goes Open Source
New Science Of Metagenomics 'Will Transform Modern Microbiology'
The Human Genome Project
The Human Genome Project (HGP) is an international research effort to characterize the genomes of human and selected model organisms through complete mapping and sequencing of their DNA, to develop technologies for genomic analysis, to examine the ethical, legal, and social implications of human genetics research, and to train scientists who will be able to utilize the tools and resources developed through the HGP to pursue biological studies that will improve human health.
Celera Genomic's mission is to become the definitive source of genomic, proteomic and related biological and medical information. Celera uses this information for an integrated information and discovery system available to researchers in pharmaceutical, biotechnology, and academic institutions on a subscription basis.